Press Releases

A groundbreaking international collaboration brought an innovative lung cancer immunotherapy from Cuba — CIMAvax-EGF — to Roswell Park Comprehensive Cancer Center. Now researchers at the Buffalo-based center are now examining whether this immunotherapy developed to treat lung cancer might prove to be an effective tool for preventing the often-deadly disease.

When cancer patients need a precise diagnosis or a second opinion, they rely on the expertise of Roswell Park Comprehensive Cancer Center’s Department of Pathology & Laboratory Medicine. Often called the “most important doctors you’ll never meet,” pathologists play a critical behind-the-scenes role to ensure proper staging and grading of disease, allowing care teams to develop personalized treatment plans. Acknowledging their dedication, Carl Morrison, MD, DVM, Chair of the Department, has recently announced several promotions within his team.

Samaritan Medical Center and Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., have announced a new affiliation, linking medical oncology services provided at Samaritan’s Walker Center for Cancer Care with the Roswell Park Care Network. The new affiliation will offer cancer patients in the North Country region access to the latest approaches and best practices in cancer treatment to enhance the quality of medical oncology services available locally.

New research from Roswell Park Comprehensive Cancer Center has uncovered genetic factors other than human leukocyte antigen (HLA) compatibility that significantly contribute to outcomes following blood and marrow transplant (BMT) in cancer patients. This study, published in the journal EClinicalMedicine, a Lancet open access journal, could lead to major changes in the way blood and marrow donors and recipients are matched as well as the development of new therapies to prevent transplant-related complications.

Day in and day out, nurses at Roswell Park Comprehensive Cancer Center deliver multidisciplinary care with expertise, passion and heart. Chief Nursing Officer Mary Ann Long, MS, RN, has promoted five veteran Nursing team members to new leadership roles in various clinical programs, and appointed another accomplished nurse to a new role at Roswell Park.

Ellis Medicine and Roswell Park Comprehensive Cancer Center marked a major milestone by cutting the ribbon on a new, much-anticipated medical oncology/chemotherapy/infusion center. Under a partnership announced in 2020, Ellis Medicine and Roswell Park are acting on their commitment to reduce cancer’s burden in both the Capital Region and throughout New York State.

With education one of the cornerstones of its mission, Roswell Park Comprehensive Cancer Center is pleased to announce that its Nurse Residency Program has achieved Accreditation with Distinction from the American Nurses Credentialing Center (ANCC). Considered the highest recognition given by the organization, the designation is noted as a global standard for residencies and fellowships in the nursing profession.

For years, scientists at Roswell Park Comprehensive Cancer Center and the University of Chicago Medicine Comprehensive Cancer Center have devoted themselves to research to better understand ovarian cancer. Although ovarian cancer is relatively rare, the disease remains the fifth deadliest cancer in women and will claim almost 14,000 lives this year. Now teams of researchers from these two leading centers are combining efforts after together securing a nearly $9 million grant from the National Cancer Institute (NCI) to develop new and better treatments for ovarian cancer.

An internationally recognized physician scientist and innovator, Roswell Park Comprehensive Cancer Center’s Carl Morrison, MD, DVM, has been promoted to Chair of Pathology and Laboratory Medicine.